Chemicals and Drugs [D] » Complex Mixtures [D20] » Biological Products » Vaccines » Bacterial Vaccines » Pertussis Vaccine
Description
A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) MeSH
Hierarchy View
Subtype Terms (2)
Diphtheria-Tetanus-acellular Pertussis Vaccines
17 drugs (10 approved, 7 experimental)
Diphtheria-Tetanus-Pertussis Vaccine
16 drugs (4 approved, 12 experimental)
Phase 4 Indicated Drugs (16)
Phase 3 Indicated Drugs (38)
bivalent oral polio vaccine (bopv), type 1 and type 3
haemophilus b conjugate vaccine diphteria crm197 protein conjugate (Menveo)
human rotavirus, live attenuated (Rotarix)
hybrid 5 component dtap, vero ipv, hep b and prp-ompc
inactivated poliovirus type 2 vaccine
Phase 2 Indicated Drugs (12)
Other Experimental Indicated Drugs (1)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
